Cambrium's mission is to trigger the next wave of material innovation by harnessing nature’s protein building blocks. Our platform combines synthetic biology, machine learning and lab automation to create high-performance materials at scale. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. We are accelerating a Cambrian explosion of biomaterials to address the world’s most pressing problems.

AI-based process analytics platform to increase productivity and quality in manual processes. Processes are captured using computer vision and automatically analysed with a highly flexible AI to identify improvement potential. 1. Real-time capture with cameras Cameras are installed at individual assembly stations capturing live video streams of assembly or packaging tasks. 2. AI tracks material & work steps Video streams are continuously analyzed to detect workpiece movements, cycle times, and work step sequencing. 3. Aggregation for data analysis Process data is aggregated per article and production to provide insights on process performance. Video snippets allow for a comprehensive root-cause analysis. 4. Data-driven improvements Your factory managers and process engineers define, implement and measure process improvements to increase productivity and quality in your assembly line.

AI for the legal system of tomorrow.

Ficus Health provides an AI-powered documentation tool that automates clinical reporting. This allows doctors to spend more time with patients, saving them several hours each day while enhancing quality and reducing costs.

Merantix Capital is a Berlin-based venture capital firm and a unit of Merantix, a group of companies and initiatives driving AI forward in Europe. We leverage our platform to attract and foster interactions between ideas, talent, industry, and policy. We combine our venture-building DNA, deep AI investing expertise, and our expansive community.

At Merantix Momentum, the experience doesn’t begin or end with their clients. It’s built from within by their people. They pride themselves on assembling the best machine learning engineers, team players, problem solvers, and creative thinkers.

Briink is an AI-powered platform designed to automate ESG workflows for sustainability teams, enabling them to efficiently collect, analyze, and verify ESG data. By leveraging advanced AI technology, Briink helps organizations streamline their ESG reporting processes, reduce costs, and improve accuracy, making it a vital tool for ESG auditors, asset managers, and corporate sustainability teams. The platform supports various ESG frameworks and regulations, allowing users to handle large volumes of documents and data seamlessly. With a focus on transparency and user control, Briink positions itself as a leader in the ESG data verification space, aiming to facilitate significant investments into sustainable assets by 2030.

Company Shield provides innovative solutions to protect businesses from cyberattacks by focusing on training and awareness programs for employees, helping organizations build a human firewall against cyber threats.

Ovom Care is a modern fertility treatment and reproductive care provider that utilizes industry-defining technology and AI to enhance patient experiences and outcomes. They offer a range of services including egg freezing, IVF, fertility testing, and personalized fertility consultations, all designed to cater to individual needs. Ovom Care differentiates itself by providing advanced care at accessible prices, significantly lower than US costs, while ensuring a serene environment for patients. Their commitment to radical transparency and personalized care positions them as a leader in the fertility care market, attracting clients from various backgrounds seeking comprehensive reproductive health solutions.

The AI Campus is a not-for-profit space where research, startups and corporates come together and collaborate on artificial intelligence projects.

The AI House is a not for profit platform for industry leaders, tech pioneers, research, companies, investors and policy makers to discuss the impact of AI on the world.

Vara is a leading AI-powered breast cancer screening company dedicated to making early detection accessible to all women. The company has developed a comprehensive platform that integrates AI technology into the entire screening pathway, enhancing the experience for patients and radiologists alike. With proven clinical evidence from the world's largest prospective study, Vara's solutions improve cancer detection rates, reduce unnecessary recalls, and streamline workflows for healthcare providers. The company collaborates with renowned research organizations and has expanded its services internationally, positioning itself as a key player in the global breast cancer screening market.